OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/12/2025
Back to search
Official data from USPTO
FROM DISCOVERY TO CURE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079115014Class
36, 41, 42, 44
Filing
79115014
Registration
4366418
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
61
Latest update
02/12/2025
Trademark type
Combined
Nice classes
36, 41, 42, 44
Filing date
01/05/2012
Registration date
07/16/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/11/2024
Last transaction
02/12/2025
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
3
Owner type
01
Owner location
DE
Examiner
TWOHIG,SHANNON MARIE
Law office
L50
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of a green four leaf clover outlined in black and white. To the right of the clover is the wording "FROM DISCOVERY TO CURE" in black.
Holders and representatives
Holders
P. K. (pessoa física)
P. S. (pessoa física)
P. S. (pessoa física)
Representatives
Patricia A. Walker Walker & Jocke Co., LPA
Technical classification
Nice Classes
Class 36Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Monetary affairsfinancial planning servicesaccepting and administering monetary charitable contributions; charitable fundraising servicescollection of monetary donations for beneficent and charitable purposes; financing of research projects and clinical studies of others; administering monetary charitable contributions for destitutesocially deprived and needy people and families for the purpose of procuring and providing benefits-in-kindfinancial advice and consultancy servicesfor the benefit of peoplein particular childrenhaving rare diseasesrare genetically caused diseasesin particular of the blood and the immune systemcongenital neutropeniacongenital disorders of the immune system and inflammatory bowel syndromefor the benefit of their families and relativesin particular in emerging and developing countries and administering monetary charitable contributions for students and physicianspharmacists and natural scientists for further education and training purposes in the field of rare diseases affecting humans
Class 41
Educational servicesproviding online instruction in the field of sciencemedicinehealthcarehygiene and nutrition via an online websitefurther training services in the field of sciencehygienenutritionhealthcare and medicine; providing medical educational servicesclassesseminars and webinars in the field of hygienenutritionrare diseasesrare genetically caused diseasesdiseases of the blood and the immune systemcongenital neutropeniacongenital disorders of the immune system and inflammatory bowel syndrome and related medical information; providing a website featuring non-downloadable electronic publications in the nature of booksmagazines and brochures in the field of sciencemedicinehealthcarehygienenutritionrare diseasesrare genetically caused diseasesdiseases of the blood and the immune system; educational servicesproviding further education in the field of science via classesseminars and workshops and organization of educational events in the field of sciencemedicinehealthcarehygiene and nutrition; organization of artistic performances and art exhibitionsvernissages and finissages; publication of printed matter in electronic form except for advertising purposesin the field of rare diseasesrare genetically caused diseasesin particular of the blood and immune systemcongenital neutropeniacongenital disorders of the immune system and inflammatory bowel diseases affecting humansin particular children
Class 42
Scientific and biological research and scientific laboratory servicestechnological research in the field of medicinebiologygeneticshealthcarechemistry and biochemistry and technological consulting services in the field of medical diagnosis systems and medical therapeutic systems; clinical and diagnostic research in the field of medicine and geneticschemicalbiologicalgenetic engineeringmolecular biological and biotechnological research; genetic engineering servicesconducting of clinical studies for pharmaceutical preparationsresearch and development services in the field of immunologygene therapy and stem cell research; conducting scientific investigations for medical purposes; drawing up scientific expert opinionsscientificmedicalclinical therapy and technical surveying; scientific researchbiologicalchemical and medical research; medical and scientific research featuring the development of new therapiesin particular pharmacotherapycell and gene therapy; basic scientific researchtherapy development and research services in the field of rare diseasesrare genetically caused diseasesin particular of the blood and immune systemcongenital neutropeniacongenital disorders of the immune system and inflammatory bowel diseases affecting humansin particular children
Class 44
Medical servicesmedical diagnostic services for testing and analysis purposes; out-patient and mobile nursing servicesmedical and therapeutic caretherapy consultancy for medical purposesproviding and arranging of medical carein the field of rare diseasesrare genetically caused diseasesin particular of the blood and immune systemcongenital neutropeniacongenital disorders of the immune system and inflammatory bowel diseases affecting humansin particular children; medical testing for diagnostic purposesclinicalimmunologicalmolecular biologicalbiochemicalchemical and genetic diagnostics in the field of rare diseasesrare genetically caused diseasesin particular of the blood and immune systemcongenital neutropeniacongenital disorders of the immune system and inflammatory bowel diseases; psychosocial counseling
Publications
History of USPTO decisions and trademark events.
61 publications found
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/12/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
05/11/2024
71AG
REGISTERED-SEC.71 ACCEPTED
05/11/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/25/2024
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
10/30/2023
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
09/16/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/09/2023
ES71
TEAS SECTION 71 RECEIVED
07/14/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/18/2022
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
07/16/2022
RNWL
INTERNATIONAL REGISTRATION RENEWED
01/20/2022
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
04/23/2021
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
04/23/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/21/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/20/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/20/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/20/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/20/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/20/2020
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
02/20/2020
PR75
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
12/28/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/01/2019
ES75
TEAS SECTION 71 & 15 RECEIVED
10/03/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/27/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/21/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/13/2014
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/25/2014
FIMP
FINAL DISPOSITION PROCESSED
02/25/2014
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/16/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
07/16/2013
GPNX
NOTIFICATION PROCESSED BY IB
07/01/2013
PUBO
PUBLISHED FOR OPPOSITION
04/30/2013
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/10/2013
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/10/2013
NPUB
NOTICE OF PUBLICATION
04/10/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/22/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/18/2013
CNEA
EXAMINERS AMENDMENT MAILED
03/18/2013
XAEC
EXAMINER'S AMENDMENT ENTERED
03/15/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/15/2013
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
03/13/2013
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
03/10/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/25/2013
ALIE
ASSIGNED TO LIE
02/24/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/13/2013
CNEA
EXAMINERS AMENDMENT MAILED
02/12/2013
XAEC
EXAMINER'S AMENDMENT ENTERED
02/12/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/12/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/11/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/06/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/06/2013
RFNT
REFUSAL PROCESSED BY IB
08/30/2012
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/08/2012
RFRR
REFUSAL PROCESSED BY MPU
08/08/2012
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/08/2012
CNRT
NON-FINAL ACTION WRITTEN
08/07/2012
MAFR
APPLICATION FILING RECEIPT MAILED
08/07/2012
DOCK
ASSIGNED TO EXAMINER
08/03/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/03/2012
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/02/2012
Continuous trademark protection
Get notified about every new filing that threatens FROM DISCOVERY TO CURE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.